About This Event

YD Bio Limited (Nasdaq: YDES), a biotechnology company focused on advancing clinical trials, new drug development, cancer prevention diagnostics, stem cell and exosome therapies with the potential to transform the treatment of diseases with high unmet medical need, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dr. Ethan Shen, Chairman & CEO rings the Opening Bell.